TP53 and neoplasm: Moreover, maintenance of aberrant p53 signaling through PLK2 has been identified in previous studies[53], further suggesting an intriguing link between PLK2 and MDM2 overexpression and defective p53 cell cycle control that may further promote aneuploidy and tumor formation.